Skip to content
  • Sunday, 26 July 2026
  • 5:40 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Eli Lilly Expands In Vivo Gene Therapy Arsenal with $7 Billion Acquisition of Kelonia Therapeutics
Pharmaceutical R&D

Eli Lilly Expands In Vivo Gene Therapy Arsenal with $7 Billion Acquisition of Kelonia Therapeutics

Teuku Ryan Apr 21, 2026 0

Eli Lilly and Company has significantly bolstered its position in the rapidly evolving cell and gene therapy (CGT) landscape with…

Read More
Pharmaceutical R&D

UCB Acquires Neurona Therapeutics for Up to $1.15 Billion to Bolster Epilepsy Pipeline with Regenerative Cell Therapy

Teuku Ryan Apr 21, 2026 0

BRUSSELS, BELGIUM & SAN FRANCISCO, USA – April 20, 2026 – Global biopharmaceutical leader UCB has finalized a definitive agreement…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment Through Epigenetic Reprogramming

Dwi Wanna Apr 18, 2026 0

Acute Myelogenous Leukemia (AML) has long remained one of the most formidable challenges in oncology, characterized by its rapid progression…

Read More
Pharmaceutical R&D

Boehringer Ingelheim and Zai Lab Forge Clinical Collaboration to Pioneer Novel Combination Therapy for Aggressive Lung Cancers

Teuku Ryan Apr 18, 2026 0

Boehringer Ingelheim and Zai Lab have announced a significant clinical collaboration aimed at investigating a dual delta-like ligand 3 (DLL3)-targeting…

Read More
Pharmaceutical R&D

Amazon Web Services Launches AI Drug Discovery Platform to Accelerate Novel Therapy Development

Teuku Ryan Apr 16, 2026 0

Amazon Web Services (AWS) has unveiled a groundbreaking artificial intelligence (AI) application designed to significantly accelerate the design and testing…

Read More
Neuroscience & Brain Research

Breakthrough Gene Therapy Offers Precise Non-Addictive Relief for Chronic Pain by Targeting Brain Circuitry

Rifan Muazin Apr 14, 2026 0

A landmark preclinical study has unveiled a novel gene therapy designed to neutralize chronic pain at its source within the…

Read More
Clinical Diagnostics & Pathology

Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs

Reynand Amr Wu Apr 14, 2026 0

A new population-based study, published in CANCER, a journal of the American Cancer Society, has brought into sharp focus a…

Read More
Stem Cell & Regenerative Medicine

Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia

Dwi Wanna Apr 11, 2026 0

The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…

Read More
Environmental & Analytical Chemistry

The Court Said Talk Therapy Is Protected Speech, Not Medical Conduct

Abdurrohim Arsyad Apr 11, 2026 0

In a landmark decision that reverberated through legal and advocacy circles, the U.S. Supreme Court ruled in late March that…

Read More
Biotech & Genetic Research

Deciphering the Distinct Roles of BET Proteins: A New Paradigm for Targeted Cancer Therapy Emerges from Max Planck Research

Jia Lissa Apr 9, 2026 0

The global fight against cancer, a disease projected to claim over 10 million lives annually, continues to drive intense research…

Read More

Posts pagination

1 … 6 7 8 9
NYC Health + Hospitals CEO Advocates for AI to Replace Radiologists, Sparking Debate Over Automation’s Role in Diagnostics and Patient SafetyBreakthrough Stainless Steel for Seawater Electrolysis Offers Scalable Path to Green Hydrogen ProductionAgentic Workflows to Automate Your Data Science PipelineLilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ